EchoStar up 13% on the week with shorts still covering and Morgan Stanley trimming its target six days before earnings
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
EchoStar added 12.8% over the past week to close at $101.94, while its closest peers moved a median of roughly flat, a sharp divergence that tracks directly with continued short covering ahead of the November 10 results.
Short interest has fallen for three consecutive weeks and now stands at 15.3% of free float, down from 19.6% in mid-October. That is a reduction of roughly 5 million shares in under a month. The absolute level remains high: 15.3% of float is not a lightly-shorted stock. But the direction has shifted decisively. The borrow market confirms the covering story without amplifying it. Availability has tightened to 154%, down from above 230% in mid-October, as demand absorbs more of the lending pool. Cost to borrow is 0.45%, near the bottom of its recent range, so there is no cost-driven squeeze at work. The 52-week low on availability was 7.5%, meaning the market is nowhere close to that kind of structural pressure. Options positioning reinforces the same lean: the put/call ratio is 0.45, more than two standard deviations below its 20-day average of 0.49, the lowest defensive reading of the past year. Taken together, the lending and options picture describes a market that is actively reducing bearish exposure, not adding to it.
The Street is broadly constructive but not uniform. Morgan Stanley maintained its Overweight rating on November 4 and trimmed its target from $134 to $132, a modest cut that places its view slightly below JP Morgan's $144 and well below UBS's $150. JP Morgan made the more significant move in October, upgrading from Underweight to Overweight with a $144 target. That is a full reversal from a bearish stance, and it landed during the same window that short covering accelerated. The consensus sits at buy, with two Overweight ratings and one Hold. At $101.94, the stock trades at a 25% to 40% discount to the range of analyst targets, which is wide even accounting for the recent rally. Valuation multiples reflect the stock's recovery: the price/earnings ratio has expanded by 2.3 points over the past 30 days to 5.6x, while EV/EBITDA has edged up to 28.3x. The earnings yield factor scores in the 58th percentile. EPS momentum scores, however, are weak: 30-day momentum ranks in the 5th percentile and 90-day in the 11th, a reminder that estimate revisions have not kept pace with the share price.
One ownership detail is worth noting explicitly. Charles Ergen holds a Schedule 13D activist position on the register, most recently disclosed at 50.9% of the class as of July 31. A 13D on the register means an activist with declared influence, not a passive investor. The 13D stake has been in place since December 2024 and has been updated 14 times. Under the standard caveat, this figure is as last disclosed; holders dropping below 5% can exit without filing again, but Ergen's position is at a level where material changes would trigger a new disclosure. Retail attention is also elevated: Wikipedia page views are running 2.97 standard deviations above their 90-day average, the highest attention reading in the dataset's recent window. That is a measure of attention, not a revenue indicator, but it does suggest the stock is drawing in a broader audience than usual.
EchoStar's last three earnings prints produced single-day moves of 0.6%, 2.4%, and 8.9%, all to the upside. The five-day return after the August 3 print was 6.0%, and after the August 7 print it was 5.6%. There is no loss-side reaction in recent history to anchor a downside scenario from the data. That said, the November 10 event was announced on November 3 with a same-day notice, which is a short runway.
The specific thing to watch on November 10 is whether the short book, still at 15.3% of float despite weeks of covering, responds to the print directionally or continues its pre-announcement retreat regardless of the result.
Stocks in this article
See the live data behind this article on ORTEX.
Open ECHO on ORTEX →How this article was generated
- Generated
- 4 Nov 2026, 20:34
- Data as of
- 4 Nov 2026, 20:33
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.